Dow up 0.58% Nasdaq up 0.47%
{"s" : "^dji,^ixic","k" : "p20","o" : "","j" : ""}
 Dow up 0.58% Nasdaq up 0.47%
{"s" : "^dji,^ixic","k" : "p20","o" : "","j" : ""}

Quote Results

Add Quotes

SymbolTime & PriceChg & % ChgDay's Low & HighVolumeAvg VolMkt CapChartMore Info
04:00pm EST 23.11 -0.01 -0.04% 22.94 23.49 3,934,172 5,541,500 6.62B Sparkline Chart Chart, News, Stats, Options, Board
Feb 16 40.71 0.00 0.00% - - 0 163,131 477.54M Sparkline Chart Chart, News, Stats, Options, Board
04:00pm EST 55.25 +0.67 +1.23% 54.39 55.60 140,045 132,890 943.73M Sparkline Chart Chart, News, Stats, Options, Board
04:00pm EST 3.38 -0.11 -3.15% 3.37 3.59 1,862,822 1,863,350 413.3M Sparkline Chart Chart, News, Stats, Options, Board
04:02pm EST 2.70 +0.05 +1.89% 2.61 2.70 39,951 55,488 296.46M Sparkline Chart Chart, News, Stats, Board
{"s" : "exel,nile,spsc,cldx,dac","k" : "t53,l84,c63,p43,g53,h53,v53,j10,c63,l84,p43,a00,a50,b00,b60,g00,h00,t53,v53","o" : "","j" : "c63,l84,p43,t53,v53"}

Quotes delayed, except where indicated otherwise.

Recent News

day and time symbols news headline and source
Danaos reports 4Q loss AP06:04pm EST
Danaos Corporation Reports Results for the Fourth Quarter and Year Ended December 31, 2016 PR Newswire04:30pm EST
SPS Commerce to Present at the JMP Securities 2017 Technology Conference GlobeNewswire09:00am EST
Patterson Companies (PDCO) Q3 Earnings: What's in Store? Zacks08:46am EST
Blue Nile, Inc. breached its 50 day moving average in a Bullish Manner : NILE-US : February 21, 2017 at Capital Cube07:27am EST
Q4 2016 Danaos Corp Earnings Release - After Market Close CCBN07:07am EST
Monday February 20, 2017
Blue Nile, Inc.: Leads amongst peers with strong fundamentals at Capital Cube04:27pm EST
Forget Alexion, Buy these 4 Biotech Stocks Instead Zacks07:52am EST
Medtronic (MDT) Q3 Earnings: Disappointment in the Cards? Zacks05:15am EST
Friday February 17, 2017
Sucampo Pharmaceuticals Set to Join S&P SmallCap 600 PR Newswire05:41pm EST
[$$] Deal Close Announcements: Feb. 13-17 at The Wall Street Journal05:12pm EST
Exelixis Announces Phase 1 Trial Results for Cabozantinib in Combination with Nivolumab with or without Ipilimumab in Refractory Metastatic Urothelial Carcinoma and Other Genitourinary Tumors Business Wire05:02pm EST
Blue Nile delists from the Nasdaq exchange Tuesday after closing $500M sale at American City Business Journals03:50pm EST
Radius Health (RDUS) Q4 Earnings: Will the Stock Disappoint? Zacks02:30pm EST
BLUE NILE INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligati EDGAR Online10:51am EST
Investor Group Completes Acquisition of Blue Nile GlobeNewswire10:23am EST
Easier Regulatory Environment Could Send Biotech Industry Skyrocketing in 2017: Today's Reports on Neuralstem and Exelixis Accesswire09:30am EST
Wednesday February 15, 2017
Danaos Corporation Announces Date for the Release of Fourth Quarter 2016 Results, Conference Call and Webcast PR Newswire04:30pm EST
SPS COMMERCE INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits EDGAR Online04:26pm EST
BLUE NILE INC Files SEC form 8-K, Regulation FD Disclosure EDGAR Online07:10am EST
Tuesday February 14, 2017
The Zacks Analyst Blog Highlights: Gilead Sciences, Celgene, Fate Therapeutics, Exelixis and Akebia Therapeutics Zacks09:30am EST
Monday February 13, 2017
Better Buy: Exelixis, Inc. vs. Bristol-Myers Squibb at Motley Fool05:17pm EST
Celldex Therapeutics Announces Upcoming Investor Presentations and 2016 Year-End Call GlobeNewswire02:45pm EST
Forget Gilead, Buy These 5 Biotech Stocks Instead Zacks09:14am EST
Friday February 10, 2017 featured highlights: Exelixis, RPC, Unit and Fortress Transportation and Infrastructure Investors Zacks09:30am EST